Bear of the Day: Becton, Dickenson and Co (BDX)
Earnings have been retreating on this Bear of the Day.
New Strong Sell Stocks for December 11th
DG, BDX and CIGI have been added to the Zacks Rank #5 (Strong Sell) List on December 11, 2023.
BD's (BDX) Novel Blood Collection System MiniDraw Gets FDA Nod
BD's (BDX) FDA approval for MiniDraw will likely reshape diagnostic testing by providing a unique design that offers blood collection at any convenient location with reduced volume.
US FDA clears Becton Dickinson's blood collection device
Becton Dickinson said on Thursday the U.S. Food and Drug Administration (FDA) had cleared its less invasive blood collection device.
BD (BDX) Launches Advanced Vascular Access Management System
BD's (BDX) SiteRite 9 Ultrasound System is likely to revolutionize vascular care by enhancing clinician efficiency and setting a new standard in first-attempt success.
Following The Q4 Results, Becton, Dickinson and Company Is Still A Hold
Becton, Dickinson, and Company is a healthcare company with strong fundamentals and a history of dividend growth. The company has shown robust execution of its 2025 strategy, positioning it for sus...
BD (BDX) Q4 Earnings In-Line With Estimates, Margins Contract
BD's (BDX) overall top line benefits from revenue growth in all its segments and both geographic regions in the fiscal fourth quarter.
Becton, Dickinson and Company (BDX) Q4 2023 Earnings Call Transcript
Becton, Dickinson and Company (NYSE:BDX ) Q43 2023 Earnings Conference Call November 9, 2023 8:00 AM ET Company Participants Greg Rodetis - Senior Vice President, Treasurer and Head of Investor Rel...
Here's What Key Metrics Tell Us About Becton Dickinson (BDX) Q4 Earnings
Although the revenue and EPS for Becton Dickinson (BDX) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare wi...
Three value stock picks from a veteran manager with a good performance record
For many years through 2022, it was becoming more difficult for active fund managers to make the case for their services, when broad index funds, with lower fees, were performing so well. But the t...
Unlocking Q4 Potential of Becton Dickinson (BDX): Exploring Wall Street Estimates for Key Metrics
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Becton Dickinson (BDX), delve into some of its key metrics to gain a deeper insight into the company's potential performance...
Becton, Dickinson And HP Among 13 Companies Announcing Annual Dividend Increases In The First Half Of November
Visa and Exxon Mobil announced dividend increases in October, with Visa increasing its dividend by 15.6% and Exxon Mobil increasing its dividend by 4.4%. Several companies, including AbbVie, Americ...
Becton, Dickinson Stock Is A Hold, Here's Why
Becton, Dickinson and Company is a global healthcare company specializing in medical supplies, devices, and diagnostic products. BDX saw solid growth in Q3 driven by strong demand for pharmacy auto...
Here's Why You Should Hold BD (BDX) Stock in Your Portfolio
BD's (BDX) slew of product launches raises optimism about the stock.
BD's (BDX) Tie-Up to Explore Flow Cytometry for Clinical Outcomes
BD's (BDX) latest partnership is likely to accelerate the delivery of innovative personalized therapies to patients who need them the most.
Related Companies